Company intelligence / Profile preview

Welocalize

Ownership: Private
Employees: ~1900
Development stage: Commercial

Overview

Welocalize provides advanced translation and localization services with a strong focus on regulated industries such as pharmaceuticals, medical devices, biotechnology, and clinical research. The company leverages AI-driven platforms to deliver compliant multilingual content at scale in over 300 languages. It supports global clinical trials, regulatory filings, pharmacovigilance reporting, device documentation localization, and patient engagement initiatives.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Over 300+ life sciences clients globally (e.g., Bayer)

Beyond the preview

Go deeper on Welocalize.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Welocalize.

Explore the full profile